uterine fibroids
Conditions
Interventions
None listed
Sponsors
KISSEI PHARMACEUTICAL CO., LTD.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Interview survey 1. Patients who will provide electronic consent to participate in the study 2. Patients aged 30 to 49 years 3. Patients who are Japanese and receiving medical treatment in Japan 4. Patients with symptoms (heavy menstrual bleeding, anemia, lower abdominal pain, etc.) due to uterine fibroids 5. Patients who are on drug treatment for uterine fibroids using drugs prescribed by a medical institution 6. Patients who have experienced any difficulty in receiving medical examination or treatment 7. Patients who answer that they can recall and explain the decision-making process prior to and upon initiation of drug therapy for uterine fibroids 2)Questionnaire survey 1. Patients who will provide electronic consent to participate in the study 2. Patients aged 30 to 49 years 3. Patients who are Japanese and receiving medical treatment in Japan 4. Patients who had symptoms (heavy menstrual bleeding, anemia, lower abdominal pain, etc.) due to uterine fibroids prior to the start of treatment 5. Patients who are on drug treatment for uterine fibroids using drugs prescribed by a medical institution
Exclusion criteria
Exclusion criteria: 1)Interview survey 1. Patients who cannot answer at all about the type of drug treatment they are receiving 2. Patients with psychiatric disorders 3. Patients who are participating in other clinical studies other than this study, including clinical trials 4. Patients with malignant tumors 5. Patients who underwent total hysterectomy for uterine fibroids 2)Questionnaire survey 1. Patients who cannot answer at all about the type of drug treatment they received 2. Patients with psychiatric disorders 3. Patients who are participating in other clinical studies other than this study, including clinical trials 4. Patients with malignant tumors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interview survey -History of the detection of uterine fibroids -History of diagnosis and treatment decision -History after the start of treatment -Experience of treatment etc. Questionnaire survey -Before treatment: -What triggered the patient to notice or suspect that the patient had uterine fibroids -The time of the patient was aware that the patient had uterine fibroids -Impact on work and life -Behavior and psychology before medical examination etc. -After the start of treatment -Triggers for medical examination for uterine fibroids -The period from recognition of symptoms and findings of uterine fibroids to medical examination -Anxiety about receiving a medical examination for uterine fibroids -The purpose of treatment and factors in determining treatment plan etc. | — |
Countries
Japan
Contacts
Public ContactHaruka Tobe
Mebix, Inc. Medical Science & Writing Group
Outcome results
None listed